Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 226 results We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read We respond to MP Dawn Butler's mission to find the Million Missing Mammograms 02 Aug 2022 1 min read We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read We respond to a new study showing how some cancer cells are able to resist PARP inhibitor drugs 11 Jan 2022 1 min read We respond to NHS England breast cancer waiting times: November 2021 13 Jan 2022 2 min read We welcome the SMC’s approval of two new treatments for use on the NHS in Scotland- trastuzumab deruxtecan (Enhertu) and tucatinib (Tukysa) in combination with trastuzumab and capecitabine 17 Jan 2022 3 min read Responding to a new AI tool being tested to establish HER2 status in breast cancer 19 Jan 2022 1 min read We respond to Professor Gilbert’s talk at UK Interdisciplinary Breast Cancer Symposium, surrounding ‘Personalised breast cancer screening’ 31 Jan 2022 1 min read Previous 1 ... 14 ... 19 Next
We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read
Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read
Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read
We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read
We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read
We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read
We respond to a new study showing how some cancer cells are able to resist PARP inhibitor drugs 11 Jan 2022 1 min read
We welcome the SMC’s approval of two new treatments for use on the NHS in Scotland- trastuzumab deruxtecan (Enhertu) and tucatinib (Tukysa) in combination with trastuzumab and capecitabine 17 Jan 2022 3 min read
Responding to a new AI tool being tested to establish HER2 status in breast cancer 19 Jan 2022 1 min read
We respond to Professor Gilbert’s talk at UK Interdisciplinary Breast Cancer Symposium, surrounding ‘Personalised breast cancer screening’ 31 Jan 2022 1 min read
